مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

991
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ORAL METOCLOPRAMIDE VERSUS PLACEBO FOR REDUCING THE INCIDENCE OF NAUSEA AND VOMITING DURING FLUORESCEIN ANGIOGRAPHY

Pages

  341-344

Abstract

 Purpose: To evaluate the efficacy of oral METOCLOPRAMIDE in reducing patients' discomfort due to NAUSEA and VOMITING and to ensure completion of the investigation.Methods: Through a double-blind randomized placebo-controlled clinical trial, 400 patients (200 as treatment group and 200 as placebo group) suffering from retinal disorders were assessed. All patients were NPO for 6 hours and received 10 mg oral metoc1opramideor placebo 1 hour before intravenous injection of 5 ml of fluorescein 10%. The injection was performed during 4-6 seconds. Patients were observed for NAUSEA or VOMITING for 30 minutes after the injection. Results: All patients completed the study. The patients were aged from 12-95 years (51.7±14.1 years) including 60% males and 40% females. VOMITING occurred in two patients of metoclopromide group (1%) and 10 cases of placebo group (5%) (RR= 5.21, P= 0.01). NAUSEA occurred in 19 patients of treatment group (9.5%) and 30 cases of placebo group (15%) (P= 0.09). Conclusion: METOCLOPRAMIDE may be indicated for prophylaxis in patients undergoing Fain order to prevent or control emesis, improve patient comfort, and ensure a successful outcome to investigation.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    FARAHI, FEREYDOUN, KHATAMINIA, GHOLAM REZA, & OSTADIAN, F.. (2003). ORAL METOCLOPRAMIDE VERSUS PLACEBO FOR REDUCING THE INCIDENCE OF NAUSEA AND VOMITING DURING FLUORESCEIN ANGIOGRAPHY. BINA, 8(4 (32)), 341-344. SID. https://sid.ir/paper/42558/en

    Vancouver: Copy

    FARAHI FEREYDOUN, KHATAMINIA GHOLAM REZA, OSTADIAN F.. ORAL METOCLOPRAMIDE VERSUS PLACEBO FOR REDUCING THE INCIDENCE OF NAUSEA AND VOMITING DURING FLUORESCEIN ANGIOGRAPHY. BINA[Internet]. 2003;8(4 (32)):341-344. Available from: https://sid.ir/paper/42558/en

    IEEE: Copy

    FEREYDOUN FARAHI, GHOLAM REZA KHATAMINIA, and F. OSTADIAN, “ORAL METOCLOPRAMIDE VERSUS PLACEBO FOR REDUCING THE INCIDENCE OF NAUSEA AND VOMITING DURING FLUORESCEIN ANGIOGRAPHY,” BINA, vol. 8, no. 4 (32), pp. 341–344, 2003, [Online]. Available: https://sid.ir/paper/42558/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button